(3,4-디메톡시비시클로[4.2.0]옥타-1,3,5-트리엔-7-일)메탄아민염산염

(3,4-디메톡시비시클로[4.2.0]옥타-1,3,5-트리엔-7-일)메탄아민염산염
(3,4-디메톡시비시클로[4.2.0]옥타-1,3,5-트리엔-7-일)메탄아민염산염 구조식 이미지
카스 번호:
35202-55-2
한글명:
(3,4-디메톡시비시클로[4.2.0]옥타-1,3,5-트리엔-7-일)메탄아민염산염
동의어(한글):
(3,4-디메톡시비시클로[4.2.0]옥타-1,3,5-트리엔-7-일)메탄아민염산염
상품명:
(3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methanamine hydrochloride
동의어(영문):
Ivabradine Impurity 9 HCl;Ivabradine Impurity 28 HCl;(3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl)methanamine;3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-methanamine Hydrochloride;(3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methanamine hydrochloride;3,4-Dimethoxy-Bicyclo[4.2.0]octa-1,3,5-triene-7-methanamine hydrochloride (1:1)
CBNumber:
CB83052277
분자식:
C11H16ClNO2
포뮬러 무게:
229.70324
MOL 파일:
35202-55-2.mol

(3,4-디메톡시비시클로[4.2.0]옥타-1,3,5-트리엔-7-일)메탄아민염산염 속성

저장 조건
Sealed in dry,Room Temperature

안전

(3,4-디메톡시비시클로[4.2.0]옥타-1,3,5-트리엔-7-일)메탄아민염산염 C화학적 특성, 용도, 생산

(3,4-디메톡시비시클로[4.2.0]옥타-1,3,5-트리엔-7-일)메탄아민염산염 준비 용품 및 원자재

원자재

준비 용품


(3,4-디메톡시비시클로[4.2.0]옥타-1,3,5-트리엔-7-일)메탄아민염산염 공급 업체

글로벌( 32)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Beijing Cooperate Pharmaceutical Co.,Ltd
010-60279497
sales01@cooperate-pharm.com CHINA 1811 55
Henan Alfa Chemical Co., Ltd
+8618339805032
alfa4@alfachem.cn China 13039 58
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49739 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 52927 58
Shanghai Likang New Materials Co., Limited
+86-16631818819 +86-17736933208
3684455296@qq.com China 9311 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131980 58
Adamas Reagent, Ltd. 400-6009262 16621234537
zhangsn@titansci.com China 14113 59
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-52878169 15701683040
sales@bjcomparison.com China 4713 58
Bide Pharmatech Ltd. 400-1647117 15221909166
product02@bidepharm.com China 41438 60
Beijing YiboYuntian Technology Co., Ltd. 13811826434
lichen13811826434@126.com China 537 58

Copyright 2019 © ChemicalBook. All rights reserved